GlassScriptPhysician profile
Kyle Alexander Bolo
NPI 1154984417
$4,682.16
in general payments reported to CMS, 2019-2025
11 companies · $870 in 2025
The $870 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.76 · 2021: $54.76 · 2022: $790 · 2023: $1,724 · 2024: $1,229 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,597 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,597.18 |
| Travel and Lodging | $225.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,997.00 | 2022-2025 | Xen Glaucoma Treatment System, Durysta, Lumigan |
| Alcon Vision LLC | $1,341.67 | 2022-2025 | Hydrus Microstent, Clareon |
| Glaukos Corporation | $263.11 | 2023-2025 | Idosetr, Istent Infinite |
| Sight Sciences, INC. | $246.34 | 2023-2024 | Omni Surgical System |
| New World Medical,INC. | $154.08 | 2023 | |
| Alimera Sciences, INC. | $144.12 | 2023 | Iluvien |
| Nova Eye, INC. | $135.57 | 2025 | |
| Bausch & Lomb Americas INC. | $108.71 | 2024-2025 | Stellaris, Miebo, Xiidra |
| Horizon Therapeutics Plc | $78.53 | 2022 | |
| Oyster Point Pharma, INC. | $77.29 | 2023 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $66.22 | 2022-2025 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Bolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.